SEC 13F Intelligence

Eagle Global Advisors LLC / ABBV

Eagle Global Advisors LLC’s Abbvie Inc Position

Does Eagle Global Advisors LLC own Abbvie Inc (ABBV)? Yes — 79.6K shares worth $17M (+0.62% of its 13F portfolio) as of Q1 2026, up from 79.6K shares the prior filed quarter.

Position Value
$17M
Q1 2026
Shares
79.6K
% of Portfolio
+0.62%
Quarters Held
21
currently held

Position History ABBV

Reported value by quarter
Q2 ’20: $320,000Q2 ’20Q3 ’20: $250,000Q3 ’21: $244,000Q4 ’21: $306,000Q4 ’21Q1 ’22: $366,000Q2 ’22: $346,000Q3 ’22: $340,000Q3 ’22Q4 ’22: $425,681Q1 ’23: $419,781Q2 ’23: $381,825Q2 ’23Q3 ’23: $422,436Q4 ’23: $510,936Q1 ’24: $12MQ1 ’24Q2 ’24: $12MQ3 ’24: $13MQ4 ’24: $14MQ4 ’24Q1 ’25: $17MQ2 ’25: $15MQ3 ’25: $18MQ3 ’25Q4 ’25: $18MQ1 ’26: $17Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202679.6K$17M+0.62%
Q4 202579.6K$18M+0.67%
Q3 202579.5K$18M+0.71%
Q2 202580.1K$15M+0.60%
Q1 202580.8K$17M+0.70%
Q4 202481.3K$14M+0.59%
Q3 202466.5K$13M+0.65%
Q2 202467.4K$12M+0.61%
Q1 202466.6K$12M+0.68%
Q4 20233.3K$510,936+0.03%
Q3 20232.8K$422,436+0.03%
Q2 20232.8K$381,825+0.03%
Q1 20232.6K$419,781+0.03%
Q4 20222.6K$425,681+0.03%
Q3 20222.5K$340,000+0.03%
Q2 20222.3K$346,000+0.03%
Q1 20222.3K$366,000+0.02%
Q4 20212.3K$306,000+0.02%
Q3 20212.3K$244,000+0.02%
Q3 20202.9K$250,000+0.02%
Q2 20203.3K$320,000+0.03%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Eagle Global Advisors LLC’s full portfolio or all institutional holders of ABBV.